New blood filter for sepsis: does it remove Life-Saving antibiotics?
NCT ID NCT06602245
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a blood-filtering device called Efferon LPS removes antibiotics from the blood of people with sepsis. Sepsis is a severe infection that can lead to organ failure, and doctors sometimes use filters to clean the blood. The study included 30 patients and measured how much antibiotic was cleared by the filter. The goal was to see if the filter might accidentally reduce antibiotic levels, which could make treatment less effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Efferon LPS hemoperfusion device
What this could lead to
If successful, this could help doctors understand how to safely use the Efferon LPS device without reducing antibiotic effectiveness in sepsis patients.
What could go wrong
This is a small pilot study with only 30 participants, so results may not apply to all patients. It only measures drug clearance, not patient outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
N. V. Sklifosovsky Moscow Research Institute of Emergency
Moscow, Russia
-
N.I. Pirogov City Clinical Hospital No. 1
Moscow, Russia
-
Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko
Nizhny Novgorod, Russia
-
Perm regional clinical hospital
Perm, Russia